GERN
Geron Corp
Price:  
2.96 
USD
Volume:  
6,246,622.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-274.5%
Upside

As of 2025-01-23, the EV/EBITDA ratio of Geron Corp (GERN) is -8.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 1,812.81 mil USD. GERN's TTM EBITDA according to its financial statements is -207.60 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.0x - 16.1x 15.0x
Forward P/E multiples 13.8x - 17.1x 14.9x
Fair Price (4.77) - (5.58) (5.16)
Upside -261.2% - -288.6% -274.5%
2.96 USD
Stock Price
(5.16) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-01-17 -8.53
2025-01-16 -8.62
2025-01-15 -8.88
2025-01-14 -8.67
2025-01-13 -8.79
2025-01-10 -9.34
2025-01-08 -10.07
2025-01-07 -10.01
2025-01-06 -10.10
2025-01-03 -10.51
2025-01-02 -10.60
2024-12-31 -10.42
2024-12-30 -10.01
2024-12-27 -9.87
2024-12-26 -9.72
2024-12-24 -9.84
2024-12-23 -9.84
2024-12-20 -10.28
2024-12-19 -10.77
2024-12-18 -11.09
2024-12-17 -11.56
2024-12-16 -11.21
2024-12-13 -11.35
2024-12-12 -11.53
2024-12-11 -11.70
2024-12-10 -11.73
2024-12-09 -11.70
2024-12-06 -11.56
2024-12-05 -11.70
2024-12-04 -11.76
2024-12-03 -11.61
2024-12-02 -11.88
2024-11-29 -12.11
2024-11-27 -12.26
2024-11-26 -11.94
2024-11-25 -12.05
2024-11-22 -11.96
2024-11-21 -11.82
2024-11-20 -11.73
2024-11-19 -11.15
2024-11-18 -11.12
2024-11-15 -10.77
2024-11-14 -10.92
2024-11-13 -11.38
2024-11-12 -11.67
2024-11-11 -12.11
2024-11-08 -12.49
2024-11-07 -12.60
2024-11-06 -12.55
2024-11-05 -12.40